Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06041321 · ClinicalTrials.gov registry record · NA
Novel Bioactive Sleeve on Pain and PROMs
A NA study of Meniscus Tear, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06041321 is a NA study of Meniscus Tear that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 100 participants, above the 77-participant average among 6 other Meniscus Tear trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06041321, a NA study of Meniscus Tear, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
A novel bioactive sleeve will be compared to a placebo sleeve with a similar look and feel to assess pain outcomes, patient reported outcome measures, and effectiveness of healing based on range of motion.
Conditions Studied
Interventions
- DEVICE Reparel Sleeve
- DEVICE Placebo Sleeve
Study Locations (1)
New York
- Orlin and Cohen Orthopedics - Woodbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-12-06 |
| Est. Completion | 2027-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06041321
The ClinicalTrials.gov registry entry for NCT06041321 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 77-participant average among 6 other Meniscus Tear trials with a reported enrollment target (30% higher). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Meniscus Tear appearing as the primary indexed condition, and to 2 interventions - of which Reparel Sleeve is the first listed.
NCT06041321 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06041321 about?
NCT06041321 is a clinical study titled "Novel Bioactive Sleeve on Pain and PROMs". A novel bioactive sleeve will be compared to a placebo sleeve with a similar look and feel to assess pain outcomes, patient reported outcome measures, and effectiveness of healing based on range of motion.
What is the current status of trial NCT06041321?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-12-06. Estimated completion is 2027-10.
What conditions does trial NCT06041321 study?
This clinical trial studies the following conditions: Meniscus Tear.
What interventions are being tested in trial NCT06041321?
The interventions under investigation include: Reparel Sleeve (DEVICE), Placebo Sleeve (DEVICE).
Who is sponsoring clinical trial NCT06041321?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06041321 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meniscus Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair
RECRUITING · NA
-
Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy
RECRUITING · NA
-
Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing
RECRUITING · Phase 1
-
Dronabinol After Arthroscopic Surgery
RECRUITING · Phase 3
-
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)
RECRUITING · Early Phase 1
-
Corticosteroid Meniscectomy Randomized Trial
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.